Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3518245rdf:typepubmed:Citationlld:pubmed
pubmed-article:3518245lifeskim:mentionsumls-concept:C0023542lld:lifeskim
pubmed-article:3518245lifeskim:mentionsumls-concept:C0033567lld:lifeskim
pubmed-article:3518245lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:3518245lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:3518245lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:3518245lifeskim:mentionsumls-concept:C1948023lld:lifeskim
pubmed-article:3518245pubmed:issue4lld:pubmed
pubmed-article:3518245pubmed:dateCreated1986-6-9lld:pubmed
pubmed-article:3518245pubmed:abstractTextSince the original discovery and structural characterization of leukotrienes, these substances have attracted considerable interest due to their numerous biological activities. It is known that these substances exert a short lasting vasoconstrictory and a longer lasting vasodilatory response. However, the cause of this biphasic response is not clear as yet. Human coronary artery segments synthesize about 50 pg PGI2/cm2/min in vitro under pressure perfusion. At concentrations ranging from 1 to 100 ng leukotrienes C4 and D4 cause a dose-dependent increase in PGI2 generation. Inhibition by acetylsalicylic acid and 15-hydroxyperoxyarachidonic acid indicates the mechanism to be mediated via the cyclooxygenase. It is, therefore, concluded that the capacity of leukotrienes C4 and D4 to stimulate PGI2 formation might play a key role during acute inflammation at the site of white blood cell accumulation.lld:pubmed
pubmed-article:3518245pubmed:languagegerlld:pubmed
pubmed-article:3518245pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3518245pubmed:citationSubsetIMlld:pubmed
pubmed-article:3518245pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3518245pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3518245pubmed:statusMEDLINElld:pubmed
pubmed-article:3518245pubmed:monthFeblld:pubmed
pubmed-article:3518245pubmed:issn0043-5325lld:pubmed
pubmed-article:3518245pubmed:authorpubmed-author:SinzingerHHlld:pubmed
pubmed-article:3518245pubmed:authorpubmed-author:KalimanJJlld:pubmed
pubmed-article:3518245pubmed:authorpubmed-author:JoskovicsGGlld:pubmed
pubmed-article:3518245pubmed:issnTypePrintlld:pubmed
pubmed-article:3518245pubmed:day21lld:pubmed
pubmed-article:3518245pubmed:volume98lld:pubmed
pubmed-article:3518245pubmed:ownerNLMlld:pubmed
pubmed-article:3518245pubmed:authorsCompleteYlld:pubmed
pubmed-article:3518245pubmed:pagination107-10lld:pubmed
pubmed-article:3518245pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3518245pubmed:meshHeadingpubmed-meshheading:3518245-...lld:pubmed
pubmed-article:3518245pubmed:meshHeadingpubmed-meshheading:3518245-...lld:pubmed
pubmed-article:3518245pubmed:meshHeadingpubmed-meshheading:3518245-...lld:pubmed
pubmed-article:3518245pubmed:meshHeadingpubmed-meshheading:3518245-...lld:pubmed
pubmed-article:3518245pubmed:meshHeadingpubmed-meshheading:3518245-...lld:pubmed
pubmed-article:3518245pubmed:meshHeadingpubmed-meshheading:3518245-...lld:pubmed
pubmed-article:3518245pubmed:meshHeadingpubmed-meshheading:3518245-...lld:pubmed
pubmed-article:3518245pubmed:meshHeadingpubmed-meshheading:3518245-...lld:pubmed
pubmed-article:3518245pubmed:year1986lld:pubmed
pubmed-article:3518245pubmed:articleTitle[Vasodilating effect of leukotriene C4 and D4 by stimulation of prostacyclin synthesis].lld:pubmed
pubmed-article:3518245pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3518245pubmed:publicationTypeEnglish Abstractlld:pubmed